AGM DisclosuresHope some of the posters here took the time to listen to the AGM presentation. Some gems in the presentation that is available in SEDAR - I encourage each of you to get it and read it:
EAA and PMX - Baxter and Spectral working closely on pre-launch activities suggests Baxter much more enthused now. Kellum did add verbally to "exceeding expectations" that results are "greatly" - so putting it together you'd have "greatly exceeding expectations". The presentation also disclosed that they have submitted to the FDA for a "breakthrough designation". I am drawing a conclusion and path - how about the rest of you?
Dialco - the presentation talks about developing a "strategic partnership" to bring in funds directly. Kellum said progressing but discussions preclude disclosure of details at this time. That implies the discussions are more advanced that the "developing" stage. Sam Amory very impressive speaking and with what he's achieved in a very short period of time. Looks like Dialco has the goods and people to get there. Seto repeated his "when not if" for DIMI in terms of FDA approval.
This one didn't leave me feeling same old...same old...just the opposite